BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 2954811)

  • 1. Which potent opioid? Important criteria for selection.
    Bovill JG
    Drugs; 1987 May; 33(5):520-30. PubMed ID: 2954811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New opioids for general anaesthesia and in- and out-hospital analgesia].
    Dabrowska-Wójciak I; Piotrowski A
    Anestezjol Intens Ter; 2008; 40(1):39-43. PubMed ID: 19469098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid agonist-antagonist drugs in acute and chronic pain states.
    Hoskin PJ; Hanks GW
    Drugs; 1991 Mar; 41(3):326-44. PubMed ID: 1711441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New morphine-type analgesics in anesthesia].
    Lehot JJ; Bastien O; Girard C; Ruynat L; Tartulier M
    Cah Anesthesiol; 1985; 33(3):239-47. PubMed ID: 2861882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic opioids compared with morphine and ketamine: catalepsy, cross-tolerance and interactions in the rat.
    Benthuysen JL; Hance AJ; Quam DD; Winters WD
    Neuropharmacology; 1989 Oct; 28(10):1011-5. PubMed ID: 2530467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid analgesics in anesthesia: with special reference to their use in cardiovascular anesthesia.
    Bovill JG; Sebel PS; Stanley TH
    Anesthesiology; 1984 Dec; 61(6):731-55. PubMed ID: 6150663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical uses of fentanyl, sufentanil, and alfentanil.
    Clotz MA; Nahata MC
    Clin Pharm; 1991 Aug; 10(8):581-93. PubMed ID: 1834393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance and cross-tolerance to the rate-suppressing effects of opioids in butorphanol-treated rats: influence of maintenance dose and relative efficacy at the mu receptor.
    Smith MA; Picker MJ
    Psychopharmacology (Berl); 1998 Nov; 140(1):57-68. PubMed ID: 9862403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sufentanil. A review of its pharmacological properties and therapeutic use.
    Monk JP; Beresford R; Ward A
    Drugs; 1988 Sep; 36(3):286-313. PubMed ID: 2903821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update.
    Scholz J; Steinfath M; Schulz M
    Clin Pharmacokinet; 1996 Oct; 31(4):275-92. PubMed ID: 8896944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sufentanil. An alternative to fentanyl/alfentanil?].
    Ellmauer S
    Anaesthesist; 1994 Mar; 43(3):143-58. PubMed ID: 8179164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, pharmacodynamics, and rational opioid selection.
    Shafer SL; Varvel JR
    Anesthesiology; 1991 Jan; 74(1):53-63. PubMed ID: 1824743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
    Picker MJ; Benyas S; Horwitz JA; Thompson K; Mathewson C; Smith MA
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects and analgesic efficacy of the agonist-antagonist opioids.
    Zola EM; McLeod DC
    Drug Intell Clin Pharm; 1983 Jun; 17(6):411-7. PubMed ID: 6861632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects of opioid agonists and agonist-antagonists in anaesthesia.
    Bowdle TA
    Drug Saf; 1998 Sep; 19(3):173-89. PubMed ID: 9747665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alfentanil causes less postoperative nausea and vomiting than equipotent doses of fentanyl or sufentanil in outpatients.
    Langevin S; Lessard MR; Trépanier CA; Baribault JP
    Anesthesiology; 1999 Dec; 91(6):1666-73. PubMed ID: 10598609
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.